GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 136 filers reported holding GENOMIC HEALTH INC in Q4 2017. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $14,000 | +16.7% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $12,000 | -14.3% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $14,000 | +7.7% | 200 | 0.0% | 0.00% | -20.0% |
| Q4 2018 | $13,000 | -7.1% | 200 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $14,000 | +40.0% | 200 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $10,000 | +66.7% | 200 | 0.0% | 0.01% | +66.7% |
| Q1 2018 | $6,000 | -14.3% | 200 | 0.0% | 0.00% | -25.0% |
| Q4 2017 | $7,000 | +16.7% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $6,000 | -14.3% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $7,000 | +16.7% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $6,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $6,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $6,000 | +20.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $5,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $5,000 | -28.6% | 200 | 0.0% | 0.00% | -20.0% |
| Q4 2015 | $7,000 | +75.0% | 200 | 0.0% | 0.01% | +66.7% |
| Q3 2015 | $4,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 13,668,866 | $353,955,000 | 3.71% |
| Camber Capital Management LP | 2,458,100 | $63,652,000 | 3.08% |
| Ghost Tree Capital, LLC | 200,000 | $5,179,000 | 1.50% |
| Tributary Capital Management, LLC | 206,291 | $5,342,000 | 0.78% |
| Motley Fool Asset Management LLC | 131,935 | $3,416,000 | 0.74% |
| CORRADO ADVISORS, LLC | 40,695 | $1,054,000 | 0.68% |
| Broadfin Capital, LLC | 270,400 | $7,002,000 | 0.68% |
| ACUTA CAPITAL PARTNERS, LLC | 48,800 | $1,264,000 | 0.61% |
| Motley Fool Wealth Management, LLC | 123,018 | $3,186,000 | 0.35% |
| TFS CAPITAL LLC | 61,773 | $1,600,000 | 0.29% |